Clinical Trial Results

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

N/AOBSERVATIONAL Columbus, Ohio

RECRUITING

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

NAINTERVENTIONAL Delray Beach, Florida +4 more

RECRUITING

Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's

NAINTERVENTIONAL Tallahassee, Florida +2 more

RECRUITING

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

PHASE3INTERVENTIONAL Homewood, Alabama +4 more

RECRUITING

Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department

N/AOBSERVATIONAL Columbus, Ohio

RECRUITING

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

PHASE3INTERVENTIONAL Chandler, Arizona +4 more

RECRUITING

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

PHASE2INTERVENTIONAL Homewood, Alabama +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

PHASE3INTERVENTIONAL Long Beach, California +4 more

RECRUITING

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

PHASE2INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING